List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 172 studies with search of: "Fentanyl"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal System
Condition: Healthy
Interventions: Drug: Fentanyl 25 μg/h transdermal system, single application;   Drug: Duragesic 25 μg/h transdermal system single application
2 Completed Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System
Condition: Healthy
Interventions: Drug: Mylan Fentanyl Transdermal System 25 mcg/h + Scotch Duct Tape (3M);   Drug: Duragesic 25 mcg/h + Scotch Duct Tape (3M);   Drug: Mylan Fentanyl Transdermal System 25 mcg/h + Blenderm Clear Plastic Surgical Tape (3M);   Drug: Duragesic 25 mcg/h + Blenderm Clear Plastic Surgical Tape (3M);   Drug: Mylan Fentanyl Transdermal System 25 mcg/h + Microfoam Tape (3M);   Drug: Duragesic 25 mcg/h + Microfoam Tape (3M)
3 Completed Staccato® Fentanyl Pharmacokinetics in Healthy Volunteers
Condition: Breakthrough Pain
Interventions: Drug: Staccato Fentanyl;   Drug: Staccato Fentanyl;   Drug: Staccato Fentanyl;   Drug: Staccato Fentanyl;   Drug: Staccato Fentanyl;   Drug: Staccato placebo
4 Completed Study of Single and Multiple Doses of Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Healthy Subjects
Condition: Healthy
Interventions: Drug: i.v. fentanyl;   Drug: 3 mL AeroLEF (500 µg/1 mL);   Drug: 3 mL AeroLEF (500 µg/1 mL)
5 Terminated Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr
Condition: Healthy
Interventions: Drug: Mylan Fentanyl Transdermal System 25 mcg/h + Clinical Procedure 1;   Drug: Mylan Fentanyl Transdermal System 25 mcg/h + Clinical Procedure 2;   Drug: Mylan Fentanyl Transdermal System 25 mcg/h + Clinical Procedure 3;   Drug: Duragesic 25 mcg/h + Clinical Procedure 1;   Drug: Duragesic 25 mcg/h + Clinical Procedure 2;   Drug: Duragesic 25 mcg/h + Clinical Procedure 3
6 Active, not recruiting Intranasal Fentanyl for Pain Management
Conditions: Trauma;   Pain
Interventions: Drug: intravenous fentanyl;   Drug: intra-nasal fentanyl
7 Not yet recruiting Epidural Fentanyl-Bupivacaine Versus Clonidine-Bupivacaine for Breakthrough Pain in Advanced Labor
Condition: Labor Pain
Intervention: Drug: Clonidine or fentanyl
8 Completed Dexmedetomidine for Immediate Perioperative Analgesia in Pediatric Patients Undergoing Tonsillectomy
Conditions: Dex vs. Fent. Intra-Oper. Hemodyn. & Post-Oper. Analg.;   Analgesic Dose Response Relationship for Dexm.;   Recovery Charac. of Dexmedetomidine vs. Fentanyl.
Interventions: Drug: Fentanyl;   Drug: Fentanyl;   Drug: Dexmedetomidine;   Drug: Dexmedetomidine
9 Recruiting Measures to Lower the Stress Response in Pediatric Cardiac Surgery
Conditions: Tetralogy of Fallot;   Ventricular Septal Defects;   Atrioventricular Septal Defects
Interventions: Drug: Fentanyl;   Drug: Fentanyl;   Drug: Dexmedetomidine and Fentanyl
10 Completed Effects of Additional Fentanyl to Epidural Bupivacaine for Post-Thoracotomy Pain in Neonates
Condition: Congenital Cystic Adenomatoid Malformation
Intervention: Drug: Fentanyl
11 Recruiting Spinal Mepivicaine With Fentanyl for Outpatient Knee Arthroscopy
Condition: Knee Arthroscopy
Interventions: Drug: Mepivacaine without fentanyl;   Drug: Mepivacaine with Fentanyl
12 Completed Study Evaluating Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Normal Healthy Subjects
Condition: Healthy
Intervention: Drug: i.v. fentanyl and AeroLEF
13 Active, not recruiting Long-Term Extension Study of BEMA™ Fentanyl
Conditions: Cancer;   Pain
Intervention: Drug: BEMA Fentanyl
14 Completed Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System
Condition: Healthy
Interventions: Drug: Fentanyl Transdermal System 25 mcg/h + Bioclusive Overlay;   Drug: Fentanyl Transdermal System 25 mcg/h
15 Completed Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System With Askina Derm Overlay
Condition: Healthy
Interventions: Drug: Fentanyl Transdermal System 25 mcg/h + Askina Derm Overlay;   Drug: Fentanyl Transdermal System 25 mcg/h
16 Recruiting Safety of Fentanyl TAIFUN Treatment
Condition: Breakthrough Cancer Pain
Interventions: Drug: Fentanyl TAIFUN;   Drug: Opioid
17 Completed Relative Bioavailability of a Fentanyl Patch
Condition: Pain
Interventions: Drug: Fentanyl patch 25 ug/nr Sandoz;   Drug: Duragesic
18 Completed Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back Pain
Condition: Low Back Pain
Intervention: Drug: fentanyl
19 Recruiting Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain
Condition: Pain, Fracture, Sprain
Interventions: Drug: Fentanyl rapid dissolving tablet 100mcg;   Drug: lansoprazole 15mg rapidly dissolving tablet + Percocet PO
20 Completed A Study to Assess the Safety and Effectiveness of Durogesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Long-Term Narcotic Pain Relief Therapy
Condition: Chronic Pain
Intervention: Drug: Durogesic® (fentanyl transdermal drug delivery system)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services